Page 9 - துணை ப்ரெஸிடெஂட் முதலீட்டாளர் உறவுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from துணை ப்ரெஸிடெஂட் முதலீட்டாளர் உறவுகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In துணை ப்ரெஸிடெஂட் முதலீட்டாளர் உறவுகள் Today - Breaking & Trending Today

U.S. Government Exercises Option for Supply of Additional Smallpox Vaccines from Bavarian Nordic

Share:
COPENHAGEN, Denmark, May 7, 2021 – Bavarian Nordic A/S ((OMX: BAVA, OTC:BVNRY) announced today that the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, has exercised the final USD 12 million option remaining under the USD 202 million order for JYNNEOS
® (Smallpox and Monkeypox Vaccine, Live, Non-replicating) awarded in April 2020.
This option covers the supply of additional liquid-frozen JYNNEOS doses which will be manufactured in the Company s new fill and finish facility during 2021. In addition, the total contract of USD 202 million for procurement includes manufacturing of bulk vaccine, which is revenue recognized in the years 2020-2022. ....

United States , Paul Chaplin , Graham Morrell , Us Department Of Health , Human Services , Biomedical Advanced Research , Development Authority , Janssen Pharmaceutical Companies Of Johnson , Us Biomedical Advanced Research , Department Of Health , Office Of The , Bavarian Nordic , Advanced Research , Assistant Secretary , Monkeypox Vaccine , Janssen Pharmaceutical Companies , Vice President Investor Relations , Paddock Circle Advisors , ஒன்றுபட்டது மாநிலங்களில் , பால் சாப்ளின் , கிரஹாம் மோரல் , எங்களுக்கு துறை ஆஃப் ஆரோக்கியம் , மனிதன் சேவைகள் , வளர்ச்சி அதிகாரம் , ஜான்சன் மருந்து நிறுவனங்கள் ஆஃப் ஜான்சன் , துறை ஆஃப் ஆரோக்கியம் ,

Bavarian Nordic A/S: U.S. Government Exercises Option for Supply of Additional Smallpox Vaccines from Bavarian Nordic

(0)
COPENHAGEN, Denmark, May 7, 2021 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, has exercised the final USD 12 million option remaining under the USD 202 million order for JYNNEOS
(Smallpox and Monkeypox Vaccine, Live, Non-replicating) awarded in April 2020.
This option covers the supply of additional liquid-frozen JYNNEOS doses which will be manufactured in the Company s new fill and finish facility during 2021. In addition, the total contract of USD 202 million for procurement includes manufacturing of bulk vaccine, which is revenue recognized in the years 2020-2022. ....

United States , Paul Chaplin , Graham Morrell , Us Department Of Health , Human Services , Biomedical Advanced Research , Development Authority , Janssen Pharmaceutical Companies Of Johnson , Us Biomedical Advanced Research , Department Of Health , Office Of The , Advanced Research , Assistant Secretary , Monkeypox Vaccine , Bavarian Nordic , Janssen Pharmaceutical Companies , Vice President Investor Relations , Paddock Circle Advisors , ஒன்றுபட்டது மாநிலங்களில் , பால் சாப்ளின் , கிரஹாம் மோரல் , எங்களுக்கு துறை ஆஃப் ஆரோக்கியம் , மனிதன் சேவைகள் , வளர்ச்சி அதிகாரம் , ஜான்சன் மருந்து நிறுவனங்கள் ஆஃப் ஜான்சன் , துறை ஆஃப் ஆரோக்கியம் ,

U.S. Government Exercises Option for Supply of Additional

Danish
COPENHAGEN, Denmark, May 7, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, has exercised the final USD 12 million option remaining under the USD 202 million order for JYNNEOS
® (Smallpox and Monkeypox Vaccine, Live, Non-replicating) awarded in April 2020.
This option covers the supply of additional liquid-frozen JYNNEOS doses which will be manufactured in the Company’s new fill and finish facility during 2021. In addition, the total contract of USD 202 million for procurement includes manufacturing of bulk vaccine, which is revenue recognized in the years 2020-2022. ....

United States , Paul Chaplin , Graham Morrell , Us Department Of Health , Human Services , Biomedical Advanced Research , Development Authority , Janssen Pharmaceutical Companies Of Johnson , Us Biomedical Advanced Research , Department Of Health , Office Of The , Bavarian Nordic , Advanced Research , Assistant Secretary , Monkeypox Vaccine , Janssen Pharmaceutical Companies , Vice President Investor Relations , Paddock Circle Advisors , ஒன்றுபட்டது மாநிலங்களில் , பால் சாப்ளின் , கிரஹாம் மோரல் , எங்களுக்கு துறை ஆஃப் ஆரோக்கியம் , மனிதன் சேவைகள் , வளர்ச்சி அதிகாரம் , ஜான்சன் மருந்து நிறுவனங்கள் ஆஃப் ஜான்சன் , துறை ஆஃப் ஆரோக்கியம் ,

Healthcare Realty Trust (HR) Q1 2021 Earnings Call Transcript

Operator
Good day and welcome to the Healthcare Realty Trust First Quarter Financial Results Conference Call. All participants will be in listen only mode. [Operator Instructions].
I would now like to turn the conference over to Carlos Baca, Associate Vice President Investor Relations and Corporate Responsibility. Please go ahead.
Carla Baca
Associate Vice President Investor Relations and Corporate Responsibility
Thank you for joining us today for healthcare royalties, first quarter 2021 earnings conference call. Joining me on the call today are; Todd Meredith, Bethany Mancini, Rob Hull and Kris Douglas. Reminder that except for the historical information contained within the matters discussed in this call may contain forward looking statements that involve estimates assumptions, risk and uncertainty. These risks are more specifically discussed in the form 10k filed with the SEC for the year ended December 31 2020. These forward looking statements represent ....

North Carolina , United States , Orange County , San Diego , San Antonio , Omotayo Okusanya Mizuho , Carlos Baca , Kris Douglas , Mike Moeller Jpmorgan , Todd Stender , Connor Siversky Berenberg , Nick Yulico , Todd Meredith , Mike Moeller , Juan Sanabria , Bethany Mancini , Rich Anderson , Vikram Malhotra , Omotayo Okusanya , Vikram Malhotra Morgan Stanley , Nick Joseph , Connor Siversky , Nick Joseph Citi , Daniel Bernstein , Morgan Stanley , Jp Morgan ,

Investegate |ConvaTec Group PLC Announcements | ConvaTec Group PLC: Result of AGM

A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
1. Obtains access to the information in a personal capacity;
2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so; ....

United Kingdom , John Mcadam , Karim Bitar , Rick Anderson , Regina Benjamin , Frank Schulkes , Heather Mason , Sten Scheibye , Constantin Coussios , Kate Postans , Margaret Ewing , Convatec Group Plc , National Storage Mechanism , Convatec Group , Annual General Meeting , Tec Group Plc , Votes Withheld , Annual Report , Director Remuneration , Brian May , Listing Rule , Vice President Investor Relations , Charles Ryland , Chris Lane , ஒன்றுபட்டது கிஂக்டம் , ஜான் மக்யாடம் ,